Deschênes J, Weidner N
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Am J Surg Pathol. 1990 Dec;14(12):1148-55. doi: 10.1097/00000478-199012000-00007.
Nucleolar organizer regions (NOR) are DNA loops encoding ribosomal RNA production. Detectable by the argyrophilia (AgNOR) of associated proteins, AgNOR numbers correlate with growth fraction and may have diagnostic and prognostic utility in human tumors. Because nucleolar size is important in the diagnosis of prostate carcinoma, we compared AgNOR counts in benign, atypical, and malignant prostate lesions and correlated them with nucleolar diameter. We counted AgNOR in benign prostatic hyperplasia, atypical adenomatous hyperplasia, intraductal dysplasias, and carcinomas of various Gleason grades. The mean AgNOR count per nucleus for benign prostatic hyperplasia nuclei was 4.51; for atypical adenomatous hyperplasia, 5.64; for intraductal dysplasias, 7.35; for carcinoma of Gleason grades 2 + 3, 8.87; and for carcinoma Gleason grades 4 + 5, 10.42. Counts in the carcinomas and intraductal dysplasias were significantly different from those of benign prostatic hyperplasia. Mean AgNOR counts of the carcinomas and intraductal dysplasias did not overlap with those of benign prostatic hyperplasia, suggesting that intraductal dysplasia shares more with carcinoma than benign prostatic hyperplasia. Nucleolar diameters increased from benign prostatic hyperplasia to atypical adenomatous hyperplasia, intraductal dysplasias, and the carcinomas, correlating with increasing AgNOR counts. Nucleolar diameters in the carcinomas were significantly different than those of benign prostatic hyperplasia; those in intraductal dysplasias were not. Our findings suggest that AgNOR counts are superior to nucleolar diameters alone in separating intraductal dysplasias from benign prostatic hyperplasia but provide no additional information in diagnosing carcinoma.
核仁组织区(NOR)是编码核糖体RNA生成的DNA环。通过相关蛋白质的嗜银性(AgNOR)可检测到,AgNOR数量与生长分数相关,并且在人类肿瘤中可能具有诊断和预后价值。由于核仁大小在前列腺癌的诊断中很重要,我们比较了良性、非典型和恶性前列腺病变中的AgNOR计数,并将它们与核仁直径相关联。我们对良性前列腺增生、非典型腺瘤样增生、导管内发育异常以及不同Gleason分级的癌进行了AgNOR计数。良性前列腺增生细胞核的平均AgNOR计数为4.51;非典型腺瘤样增生为5.64;导管内发育异常为7.35;Gleason分级2 + 3的癌为8.87;Gleason分级4 + 5的癌为10.42。癌和导管内发育异常的计数与良性前列腺增生的计数有显著差异。癌和导管内发育异常的平均AgNOR计数与良性前列腺增生的计数没有重叠,这表明导管内发育异常与癌的共同特征比与良性前列腺增生更多。核仁直径从良性前列腺增生到非典型腺瘤样增生、导管内发育异常以及癌逐渐增加,与AgNOR计数的增加相关。癌中的核仁直径与良性前列腺增生的核仁直径有显著差异;导管内发育异常中的核仁直径则无显著差异。我们的研究结果表明,在将导管内发育异常与良性前列腺增生区分开来方面,AgNOR计数优于单独的核仁直径,但在诊断癌方面没有提供额外信息。